ReShape Lifesciences (Formally known as EnteroMedics)

280 articles about ReShape Lifesciences (Formally known as EnteroMedics)

• EnteroMedics Announces Affordable vBloc Therapy Program For Weight Loss Patients

  6/28/2017

• EnteroMedics Added To Russell Microcap Index

  6/26/2017

• Entest Biomedical, Inc.'s Subsidiary EnteroMedics Reports On Preliminary Canine Experiments Testing New Anti-Inflammatory Drug Compounds

  6/7/2017

• EnteroMedics Announces First vBloc Neurometabolic Therapy Implant At AMITA Health Adventist Medical Center Bolingbrook

  5/31/2017

• EnteroMedics Surges on BarioSurg Buyout

  5/23/2017

• EnteroMedics Announces First vBloc Neurometabolic Therapy Implant At Mcguire Veterans Affairs Medical Center

  5/18/2017

• EnteroMedics Announces First Quarter 2017 Financial Results And Conference Call

  5/16/2017

• EnteroMedics To Host First Quarter 2017 Conference Call

  5/11/2017

• EnteroMedics' vBloc Neurometabolic Therapy Featured On "The Doctors" TV Show

  3/14/2017

• EnteroMedics Reports Fourth Quarter 2016 Financial Results

  3/7/2017

• EnteroMedics Regains Compliance With Nasdaq Listing Requirement

  2/21/2017

• EnteroMedics Announces Publication Of Three-Year Data From vBloc Diabetic Patient Study In Journal Of Diabetes And Obesity

  2/9/2017

• EnteroMedics Release: Medical Device Company Announces Closing Of $19.0 Million Underwritten Public Offering And Full Exercise Of Over-Allotment Option

  1/23/2017

• EnteroMedics Release: Company Announces Pricing Of $16.5 Million Underwritten Public Offering

  1/18/2017

• EnteroMedics Announces vBloc Neurometabolic Therapy Now Available At MedStar Health And Roper St. Francis

  1/5/2017

• EnteroMedics Announces Retirement of All Senior Convertible Notes

  12/29/2016

• EnteroMedics Announces 1-for-70 Reverse Stock Split

  12/27/2016

• Commercial Patient Data Confirms Success of EnteroMedics' vBloc Therapy In Combination With vBloc Achieve Program In Patients Struggling To Lose Weight

  12/15/2016

• In Update, EnteroMedics to Continue Pursuing vBloc Therapy Positive Payer Coverage

  11/22/2016

• EnteroMedics Reports Third Quarter 2016 Financial Results

  11/11/2016